Use of remimazolam as an adjunct to general anesthesia for an adolescent with MELAS syndrome.

• Egile Nagusiak: N. Gyurgyik (Egilea), J. Warren (Egilea), R. Miketic (Egilea), J. D. Tobias (Egilea)
• Formatua: Liburua
• Argitaratua: Pediatric Anesthesia and Critical Care Journal, 2022-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

MELAS syndrome is an acronym so named because of the characteristic clinical and pathophysiologic features including mitochondrial encephalo-myopathy, lactic aci- dosis, and stroke-like episodes. As the disorder impacts mitochondrial function and oxidative phosphorylation, clinical symptoms characte...